LESI | Print Page | Sign In | Join
Boston: Building, Licensing, and Commercializing an AI IP Portfolio
Tell a Friend About This EventTell a Friend
 

hosted by the Boston Chapter

11/14/2024
When: Thursday, November 14, 2024
4:00pm - 7:00pm ET
Where: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Two Seaport Lane
6th Floor
Boston, Massachusetts  02210
United States
Contact: chapters@les.org


Online registration is closed.
« Go to Upcoming Event List  


 

Building, Licensing, and Commercializing an AI IP Portfolio
hosted by the Boston Chapter

Thursday, November 14, 2024

4:00 pm - 5:30 pm - Panel Discussion
5:30pm - 7:00pm - Networking
at
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Two Seaport Lane
6th Floor
Boston, MA 02210

Building access:
When attendees arrive at Two Seaport Lane, they should provide their name to security in the lobby,
who will grant access to the Finnegan offices on the sixth floor.

Parking:
The closest parking garage is located at the Seaport Hotel. The address is One Seaport Lane.

The building is also easily accessible by MBTA. From South Station take the
MBTA Silver Line Waterfront service to the World Trade Center Station.
The Silver Line operates approximately every 10 minutes during peak hours
and every 15 minutes during off‐peak hours.


Thank you to our host:

Program:
Join a panel of experts to discuss business strategies for commercializing and licensing AI innovations, how to build an IP portfolio that supports those strategies, and key terms to address in licensing negotiations from both the licensor and licensee perspective. Panelists will share insights on different approaches to commercializing and licensing AI technology, including AI platforms for drug discovery, generative AI platforms, and consumer products that incorporate AI functionality.

Light bites, wine, beer, and soft drinks will be served.

Speakers:


Moderator: Scott Forman, Of Counsel, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Scott Forman has spent a decade advising public and private clients in biotechnology and other technology-focused industries on strategic transactions, IP licensing, commercial contracts, IP litigation, patent prosecution, and other IP matters. He leverages his chemistry background and experience handling matters across the spectrum of IP and technologies to learn clients’ businesses, identify risks, and propose practical legal and business solutions to meet their goals.


Jennifer Burdman, Managing Director, Sauvegarder Investment Management

Jennifer Burdman is Managing Director at Sauvegarder Investment Management, a multi-strategy investment firm dedicated to IP-related financing and investment opportunities including structured senior debt, structured equity, and high-value licensing and monetization campaigns. Jennifer focuses on developing robust IP creation and monetization strategies.

Jennifer is also co-chair of the Life Sciences Committee of Licensing Executives Society International. She previously served as VP, Chief IP Officer and Deputy General Counsel at Valo Health and PolarityTE, and as a law firm IP trial lawyer.

Jennifer has been named one of the “Top 25 Women Leaders in Biotechnology of 2020” by The Healthcare Technology Report and a National Law Journal “Rising Star” (40 under 40) in Washington, D.C. for 2015; profiled as a Law360 “Rising Star” in 2016; named to Law360’s 2016 Intellectual Property Editorial Advisory Board and Benchmark Litigation’s “Under 40 Hot List” in 2016 and 2017; and published in LESI's Les Nouvelles, Bloomberg BNA Daily Report for Executives and the Intellectual Property & Technology Law Journal, among others.


Gideon Myles, Associate General Counsel, Patents and Trademarks, OpenAI

Gideon Myles is Associate General Counsel, Patents and Trademarks at OpenAI. Gideon specializes in all aspects of intellectual property, including the development and day-to-day execution of patent, trademark, and open source strategies, policies, and procedures.

He previously served as Senior Director, Head of Intellectual Property at Dropbox, a software engineer at Apple and IBM Research, and a patent attorney in private practice. Gideon holds a PhD in Computer Science and a JD from Santa Clara Law School.


David Soucy, Senior Intellectual Property Counsel and Global Lead Patent Counsel, SimpliSafe

David Soucy is an experienced attorney specializing in technology and intellectual property law. He has managed patent prosecution, litigation, and client counseling in both startups and established companies. Before joining SimpliSafe, David represented Fortune 100 clients in private practice and later transitioned in-house to oversee IP strategies for a publicly traded technology firm, where his efforts helped secure recognition in the Intellectual Property Owners Top 300 Companies Granted U.S. Patents.

In addition to his professional accomplishments, David has contributed to legal scholarship through articles in the Fordham University Intellectual Property, Media & Entertainment Law Journal (2024), the UIC Review of Intellectual Property Law (2023), and the Marquette Intellectual Property Law Review (2022), reflecting his commitment to advancing the field.

He holds a J.D. from the University of New Hampshire Franklin Pierce School of Law and a B.S. in Mechanical Engineering. He is admitted to the New Hampshire State Bar and is licensed before the U.S. Patent and Trademark Office.



Email Consent:  By registering for this event, you permit LES to use your email address to communicate with you regarding LES events and their other services. You will have the ability to unsubscribe from these communications going forward.

Sponsors

Connect with more than 500 intellectual capital management decision-makers and thought leaders around the world.  Join us at the LES 2024 Annual Meeting as a sponsor to promote your company and discover new business opportunities. Learn more

 

401 Edgewater Place, Suite 600, Wakefield, MA 01880
Phone: 703-234-4058 Fax: 703-234-4147
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.